Unknown

Dataset Information

0

Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-? signaling.


ABSTRACT: Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer is the only bacterial cancer therapy approved for clinical use. Although presumed to induce T cell-mediated immunity, whether tumor elimination depends on bacteria-specific or tumor-specific immunity is unknown. Herein we show that BCG-induced bladder tumor elimination requires CD4 and CD8 T cells, although augmentation or inhibition of bacterial antigen-specific T cell responses does not alter the efficacy of BCG-induced tumor elimination. In contrast, BCG stimulates long-term tumor-specific immunity that primarily depends on CD4 T cells. We demonstrate that BCG therapy results in enhanced effector function of tumor-specific CD4 T cells, mainly through enhanced production of IFN-?. Accordingly, BCG-induced tumor elimination and tumor-specific immune memory require tumor cell expression of the IFN-? receptor, but not MHC class II. Our findings establish that a bacterial immunotherapy for cancer is capable of inducing tumor immunity, an antitumor effect that results from enhanced function of tumor-specific CD4 T cells, and ultimately requires tumor-intrinsic IFN-? signaling, via a mechanism that is distinct from other tumor immunotherapies.

SUBMITTER: Antonelli AC 

PROVIDER: S-EPMC7414065 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling.

Antonelli Anthony C AC   Binyamin Anna A   Hohl Tobias M TM   Glickman Michael S MS   Redelman-Sidi Gil G  

Proceedings of the National Academy of Sciences of the United States of America 20200717 31


Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer is the only bacterial cancer therapy approved for clinical use. Although presumed to induce T cell-mediated immunity, whether tumor elimination depends on bacteria-specific or tumor-specific immunity is unknown. Herein we show that BCG-induced bladder tumor elimination requires CD4 and CD8 T cells, although augmentation or inhibition of bacterial antigen-specific T cell responses does not alter the efficacy of BCG-induced tumor elim  ...[more]

Similar Datasets

| S-EPMC10746157 | biostudies-literature
| S-EPMC8081932 | biostudies-literature
| S-EPMC7225951 | biostudies-literature
| S-EPMC10883360 | biostudies-literature
| S-EPMC6143921 | biostudies-literature
| S-EPMC8924142 | biostudies-literature
2023-04-24 | GSE160638 | GEO
| S-EPMC5509332 | biostudies-literature
| S-EPMC9880184 | biostudies-literature
| S-EPMC8597981 | biostudies-literature